NCT01665417_exc_text
exclusion
Prior chemotherapy Prior treatment with gefitinib, erlotinib, or other drugs that target EGFR Patients must not be receiving any other investigational agents Any evidence of interstitial lung disease

NCT01665417_exc_T1
Procedure
chemotherapy
NCT01665417_exc_T2
Temporal
Prior
NCT01665417_exc_T4
Procedure
treatment
NCT01665417_exc_T5
Drug
gefitinib
NCT01665417_exc_T6
Temporal
Prior
NCT01665417_exc_T8
Drug
erlotinib
NCT01665417_exc_T7
Drug
drugs that target EGFR
NCT01665417_exc_T9
Scope
gefitinib, erlotinib, or other drugs that target EGFR
NCT01665417_exc_T12
Condition
interstitial lung disease